Volume 18, Issue 3

Search all Gastric Cancer articles

July 2015

27 articles in this issue

Robotic surgery for gastric cancer
Masanori Terashima
Masanori Tokunaga
Fumiko Hirata
Review Article 22 April 2015 Pages: 449 - 457
A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity
Yasunori Nishida
Takeshi Kuwata
Atsushi Ochiai
Original Article 11 June 2014 Pages: 458 - 466
HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)
Tomohiro Matsumoto
Mitsuru Sasako
Stomach Cancer Study Group of the Japan Clinical Oncology Group
Original Article 04 July 2014 Pages: 467 - 475
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
Eric Van Cutsem
Yung-Jue Bang
Josef Rüschoff
Original Article Open access 20 July 2014 Pages: 476 - 484
Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer
Shojiro Kikuchi
Nobuaki Kaibe
Mitsuru Sasako
Original Article 08 June 2014 Pages: 485 - 494
Gene polymorphisms in the ornithine decarboxylase–polyamine pathway modify gastric cancer risk by interaction with isoflavone concentrations
Lisa Y. Cho
Jae Jeong Yang
Sue K. Park
Original Article 31 July 2014 Pages: 495 - 503
Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin α3β1-dependent adhesion
Chiung-Nien Chen
Cheng-Chi Chang
Hsinyu Lee
Original Article 02 July 2014 Pages: 504 - 515
Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer
Chunping Du
Nobuya Kurabe
Haruhiko Sugimura
Original Article 07 August 2014 Pages: 516 - 525
Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa
Yoon Jin Choi
Nayoung Kim
Hyun Chae Jung
Original Article 14 August 2014 Pages: 526 - 537
Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer
Mitsuru Sasako
Masanori Terashima
Hiroshi Imamura
Original Article Open access 12 August 2014 Pages: 538 - 548
Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer
Mitsuru Sasako
Masanori Terashima
Hiroshi Imamura
Erratum Open access 08 October 2014 Pages: 549 - 549
International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus
Markus Moehler
Christoph T. H. Baltin
Stefan P. Mönig
Original Article 07 September 2014 Pages: 550 - 563
Gastric cancer in patients with type I gastric carcinoids
Edith Lahner
Gianluca Esposito
Bruno Annibale
Original Article 03 June 2014 Pages: 564 - 570
Indigenous inequities in the presentation and management of stomach cancer in New Zealand: a country with universal health care coverage
Virginia Signal
Diana Sarfati
Lis Ellison-Loschmann
Original Article 07 August 2014 Pages: 571 - 579
Age and sex interactions in gastric cancer incidence and mortality trends in Korea
Minkyo Song
Daehee Kang
Woo Ho Kim
Original Article 05 August 2014 Pages: 580 - 589
Can we accurately diagnose minute gastric cancers (≤5 mm)? Chromoendoscopy (CE) vs magnifying endoscopy with narrow band imaging (M-NBI)
Shoko Fujiwara
Kenshi Yao
Toshiyuki Matsui
Original Article 09 July 2014 Pages: 590 - 596
Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A)
Kenichi Nakamura
Takeshi Kuwata
Haruhiko Fukuda
Original Article 27 June 2014 Pages: 597 - 604
Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy
Takuji Gotoda
Hideki Ishikawa
Fuminori Moriyasu
Original Article 13 August 2014 Pages: 605 - 611
Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study
Kazuhide Higuchi
Toshihisa Takeuchi
Takeshi Azuma
Original Article 07 August 2014 Pages: 612 - 617
Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity
Byung-Hoon Min
Kyoung-Mee Kim
Jae J. Kim
Original Article 07 May 2014 Pages: 618 - 626
Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo
Chris D. Poole
Mark P. Connolly
Craig J. Currie
Original Article Open access 24 June 2014 Pages: 627 - 634
Effectiveness of plasma treatment on gastric cancer cells
Koji Torii
Suguru Yamada
Yasuhiro Kodera
Original Article 06 July 2014 Pages: 635 - 643
Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer
Der Sheng Sun
Eun Kyoung Jeon
Yoon Ho Ko
Original Article 07 August 2014 Pages: 644 - 652
Predictors of postoperative complications in elderly and oldest old patients with gastric cancer
Takehiro Takama
Keiichi Okano
Yasuyuki Suzuki
Original Article 30 May 2014 Pages: 653 - 661
Critical factors that influence the early outcome of laparoscopic total gastrectomy
Yuichiro Kawamura
Seiji Satoh
Ichiro Uyama
Original Article 07 June 2014 Pages: 662 - 668
Clinical outcome of lower esophageal sphincter- and vagus-nerve-preserving partial cardiectomy for early gastric cancer of the subcardia
Hideo Matsumoto
Haruaki Murakami
Toshihiro Hirai
Original Article 07 June 2014 Pages: 669 - 674
Evaluation of postgastrectomy symptoms after distal gastrectomy with Billroth-I reconstruction using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45)
Kazunari Misawa
Masanori Terashima
Koji Nakada
Original Article 05 August 2014 Pages: 675 - 681

Volume 18, Issue 3

Robotic surgery for gastric cancer

A novel gene–protein assay for evaluating HER2 status in gastric cancer: simultaneous analyses of HER2 protein overexpression and gene amplification reveal intratumoral heterogeneity

HER2 expression in locally advanced gastric cancer with extensive lymph node (bulky N2 or paraaortic) metastasis (JCOG1005-A trial)

HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer

Overexpression of Ephrin A2 receptors in cancer stromal cells is a prognostic factor for the relapse of gastric cancer

Gene polymorphisms in the ornithine decarboxylase–polyamine pathway modify gastric cancer risk by interaction with isoflavone concentrations

Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin α3β1-dependent adhesion

Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer

Influence of TGFB1 C-509T polymorphism on gastric cancer risk associated with TGF-β1 expression in the gastric mucosa

Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer

Erratum to: Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer

International comparison of the German evidence-based S3-guidelines on the diagnosis and multimodal treatment of early and locally advanced gastric cancer, including adenocarcinoma of the lower esophagus

Gastric cancer in patients with type I gastric carcinoids

Indigenous inequities in the presentation and management of stomach cancer in New Zealand: a country with universal health care coverage

Age and sex interactions in gastric cancer incidence and mortality trends in Korea

Can we accurately diagnose minute gastric cancers (≤5 mm)? Chromoendoscopy (CE) vs magnifying endoscopy with narrow band imaging (M-NBI)

Determination of the optimal cutoff percentage of residual tumors to define the pathological response rate for gastric cancer treated with preoperative therapy (JCOG1004-A)

Randomized controlled trial comparing gastric cancer screening by gastrointestinal X-ray with serology for Helicobacter pylori and pepsinogens followed by gastrointestinal endoscopy

Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study

Outcomes of endoscopic submucosal dissection for differentiated-type early gastric cancer with histological heterogeneity

Health utility of patients with advanced gastrointestinal stromal tumors (GIST) after failure of imatinib and sunitinib: findings from GRID, a randomized, double-blind, placebo-controlled phase III study of regorafenib versus placebo

Effectiveness of plasma treatment on gastric cancer cells

Outcomes in elderly patients treated with a single-agent or combination regimen as first-line chemotherapy for recurrent or metastatic gastric cancer

Predictors of postoperative complications in elderly and oldest old patients with gastric cancer

Critical factors that influence the early outcome of laparoscopic total gastrectomy

Clinical outcome of lower esophageal sphincter- and vagus-nerve-preserving partial cardiectomy for early gastric cancer of the subcardia

Evaluation of postgastrectomy symptoms after distal gastrectomy with Billroth-I reconstruction using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45)

Navigation